Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LTR Pharma Limited ( (AU:LTP) ) just unveiled an announcement.
LTR Pharma Limited has notified the market of the issue of 8.3 million unquoted options, exercisable at A$0.60 and expiring on 16 January 2028. The options, which are not intended to be quoted on the ASX, form part of previously announced transactions and indicate the company’s continued use of equity-linked incentives or financing structures that may lead to future dilution but can support capital management and alignment of stakeholder interests.
More about LTR Pharma Limited
LTR Pharma Limited is an Australian pharmaceutical company listed on the ASX under the code LTP. The company operates in the life sciences sector, focusing on the development and commercialisation of pharmaceutical products, with its securities traded on the Australian market.
Average Trading Volume: 348,747
Technical Sentiment Signal: Buy
Current Market Cap: A$108.1M
For detailed information about LTP stock, go to TipRanks’ Stock Analysis page.